BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22226213)

  • 1. [Berger disease: therapeutic algorithm proposal and chronic renal failure predictive factors].
    Pessegueiro P; Barata C; Correia J
    Acta Med Port; 2003; 16(4):261-6. PubMed ID: 22226213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and natural history of IgA nephropathy.
    Rychlik I; Andrassy K; Waldherr R; Zuna I; Tesar V; Jancová E; Stejskalová A; Ritz E
    Ann Med Interne (Paris); 1999 Feb; 150(2):117-26. PubMed ID: 10392260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T; Najafi I; Salimi BH; Broomand B
    Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute renal failure in IgA nephropathy.
    Packham DK; Hewitson TD; Yan HD; Elliott CE; Nicholls K; Becker GJ
    Clin Nephrol; 1994 Dec; 42(6):349-53. PubMed ID: 7882597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macroscopic hematuria in childhood IgA nephropathy.
    Yoshikawa N; Ito H; Iijima K; Nakahara C; Maehara K; Hasegawa O; Okada S; Matsuo T
    Clin Nephrol; 1987 Nov; 28(5):217-21. PubMed ID: 3427831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgA nephropathy: the presence of familial disease does not confer an increased risk for progression.
    Izzi C; Ravani P; Torres D; Prati E; Viola BF; Guerini S; Foramitti M; Frascà G; Amoroso A; Ghiggeri GM; Schena FP; Scolari F
    Am J Kidney Dis; 2006 May; 47(5):761-9. PubMed ID: 16632014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berger's disease in children. Natural history and outcome.
    Lévy M; Gonzalez-Burchard G; Broyer M; Dommergues JP; Foulard M; Sorez JP; Habib R
    Medicine (Baltimore); 1985 May; 64(3):157-80. PubMed ID: 3887094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin A nephropathy and chronic kidney disease.
    Tomino Y
    Nephrology (Carlton); 2010 Jun; 15 Suppl 2():23-6. PubMed ID: 20586943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
    Komatsu H; Fujimoto S; Hara S; Sato Y; Yamada K; Eto T; Nakao H
    Ren Fail; 2005; 27(1):45-52. PubMed ID: 15717634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematuria and risk for end-stage kidney disease.
    Vivante A; Calderon-Margalit R; Skorecki K
    Curr Opin Nephrol Hypertens; 2013 May; 22(3):325-30. PubMed ID: 23449218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA nephropathy in teaching hospitals of Dhaka.
    Sharmin F; Khan BR; Rahman M; Rashid HU; Islam B; Kamal M; Barua AR; Chowdhury MA; Mohsin AU; Ahmed S
    Bangladesh Med Res Counc Bull; 1997 Apr; 23(1):25-9. PubMed ID: 9363674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinuria in IgA nephropathy.
    Neelakantappa K; Gallo GR; Baldwin DS
    Semin Nephrol; 1987 Dec; 7(4):344-5. PubMed ID: 3445012
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute renal failure in IgA nephropathy: aggravation by gross hematuria due to anticoagulant treatment.
    August C; Atzeni A; Köster L; Heidenreich S; Lang D
    J Nephrol; 2002; 15(6):709-12. PubMed ID: 12495289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of IgA nephropathy in patients followed-up for more than ten years in Spain.
    Velo M; Lozano L; Egido J; Gutierrez-Millet V; Hernando L
    Semin Nephrol; 1987 Dec; 7(4):346-50. PubMed ID: 3445013
    [No Abstract]   [Full Text] [Related]  

  • 16. [Glomerulonephritis with IgA mesangial deposits].
    Pillebout E; Nochy D
    Nephrol Ther; 2010 Nov; 6(6):545-57. PubMed ID: 20399170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [First case of primary IgA glomerulonephritis (Berger's disease) in Senegal].
    Diouf B; Diao M; Niang A; Ka EF; Moreira Diop T
    Dakar Med; 1999; 44(1):140-2. PubMed ID: 10798006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic features and outcomes in endocapillary proliferative IgA nephropathy.
    Liu LJ; Li GT; Zhou Y; Lv JC; Zhang H
    Nephron Clin Pract; 2010; 115(2):c161-7. PubMed ID: 20407276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent IgA nephropathy in renal transplant allografts.
    Wang AY; Lai FM; Yu AW; Lam PK; Chow KM; Choi PC; Lui SF; Li PK
    Am J Kidney Dis; 2001 Sep; 38(3):588-96. PubMed ID: 11532693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [IgA-nephropathy in childhood].
    de Jong MC; van Dael CM; van Damme B
    Tijdschr Kindergeneeskd; 1990 Apr; 58(2):60-4. PubMed ID: 2349559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.